浙江九洲药业股份有限公司第八届董事会第十八次会议决议公告

Group 1 - The board of directors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. held its 18th meeting of the 8th session on November 12, 2025, with all 9 directors present, confirming the legality and validity of the meeting [2][4] - The board approved the election of Ms. Hua Lirong as the representative director to execute company affairs and as the legal representative, with her term lasting until the end of the current board's term [3][4] - The board also approved the election of members for the audit committee, including Ms. Jiang Qi, Mr. Yang Lirong, and Mr. Li Jicheng, with Ms. Jiang serving as the committee's convener [5][6] Group 2 - The audit committee is composed of a majority of independent directors, complying with relevant laws and regulations [5] - The term for the newly elected audit committee members will also last until the end of the current board's term [5]